Top Buy
| Wertpapier | Buy | Sell ▲ | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Exelixis Inc. | 18 | 0 | 0 | 0 | 20,00 € | 26,01 € | 30,03 % |
| Madrigal Pharmaceuticals inc. | 4 | 0 | 0 | 0 | 217,00 € | 315,00 € | 45,16 % |
| United Therapeutics | 20 | 0 | 2 | 0 | 256,00 € | 287,40 € | 12,27 % |
| Lexicon Pharmaceuticals Inc. | 2 | 0 | 0 | 0 | 1,68 € | 5,34 € | 218,19 % |
| Halozyme Therapeutics Inc. | 16 | 0 | 3 | 0 | 41,97 € | 47,07 € | 12,16 % |
| Vanda Pharmaceuticals | 4 | 0 | 0 | 0 | 4,72 € | 5,00 € | 5,93 % |
| Neurocrine Bioscience | 31 | 0 | 4 | 0 | 122,95 € | 140,60 € | 14,36 % |
| Geron Corp. | 12 | 0 | 0 | 0 | 3,76 € | 4,63 € | 23,06 % |
| Dynavax Technologies Corp | 2 | 0 | 1 | 0 | 11,13 € | 26,95 € | 142,24 % |
| Amgen Inc. | 25 | 0 | 2 | 0 | 282,65 € | 297,31 € | 5,19 % |
| Innoviva Inc. | 3 | 0 | 0 | 0 | 14,70 € | 30,00 € | 104,08 % |
| Alnylam Pharmace. | 36 | 0 | 1 | 0 | 137,80 € | 236,30 € | 71,48 % |
| Biocryst Pharmaceuticals | 9 | 0 | 2 | 0 | 6,23 € | 11,05 € | 77,27 % |
| Brainstorm Cell | 1 | 0 | 0 | 0 | 0,46 € | - | - |
| AbbVie Inc. | 23 | 0 | 2 | 0 | 152,18 € | 174,43 € | 14,62 % |
| Abbott Laboratories | 18 | 0 | 2 | 0 | 94,95 € | 116,48 € | 22,68 % |
| Corcept Therapeutics Inc. | 13 | 0 | 2 | 0 | 30,59 € | 36,87 € | 20,52 % |
| Rigel Pharmaceutical Inc. | 11 | 0 | 2 | 0 | 0,90 € | 13,78 € | 1434,93 % |
| Eli Lilly Corp. | 49 | 0 | 3 | 0 | 765,10 € | 786,51 € | 2,80 % |
| Repligen Corp. | 13 | 0 | 0 | 0 | 138,65 € | 184,76 € | 33,26 % |
| Immunogen Inc. | 4 | 0 | 0 | 0 | 28,97 € | - | - |
| Anika Therapeutics | 5 | 0 | 1 | 0 | 24,40 € | 28,29 € | 15,95 % |
| Amicus Therapeutics Inc. | 7 | 0 | 4 | 0 | 9,45 € | 17,64 € | 86,64 % |